© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
227774 |
As an accredited 2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Many years working in chemical research introduced me to the puzzle of finding materials that actually do what they promise. Research and development don’t just need any old reagent; breakthroughs depend on consistently high standards. 2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine represents a prime example of this standard. This isn’t a chemical that just fills space on a shelf; instead, it provides researchers a real solution in heterocyclic synthesis, pharmaceutical precursor work, and agrochemical explorations.
2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine brings together a unique blend of halogen, amino, and trifluoromethyl groups on one pyridine ring. That arrangement catches attention for more reasons than just its tongue-twister name. The trifluoromethyl piece, for example, often helps pharmaceutical chemists improve a molecule’s metabolic stability, sometimes giving new life to compounds that might otherwise get broken down too quickly in the body. The bromine atom stands ready for cross-coupling reactions like Suzuki or Buchwald-Hartwig, which chemists often rely on in drug discovery. The amino group, on its own, can be the handle for a string of derivatizations—a practical launching pad for new compounds.
This compound, with its chemical formula C6H3BrF3N2, weighs in at a molecular mass of about 257.01 g/mol. The purity you’re likely to encounter runs well above 97 percent, with reliable manufacturers describing strict quality control on every batch. In the lab, researchers have noted its crystalline solid form, lending easier handling compared to many sticky or volatile chemicals. Melting points, often a clue to stability, hover in the broad range reported for similar pyridines, but what matters more is the consistent performance from one batch to the next, especially for those chasing subtle bioactivity differences or reproducible catalyst results.
Access to robust spectral data often makes or breaks the scale-up project. Analysts appreciate access to NMR and HPLC profiles that leave little doubt about identity and purity. 2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine typically comes with sharp signals across 1H and 13C NMR spectra. The handy CF3 group tends to pop out in 19F NMR as well, providing another fingerprint chemists can use to confirm their target. The more experience you gain handling new aromatic building blocks, the more you value solid documentation. In my own work, the difference between wasted weeks and an early result often comes down to thorough, well-interpreted analysis like this.
Not all building blocks behave the same. Synthetic chemists often talk shop about the quirks of different pyridine derivatives. This one shows up most often in the medicinal chemistry routes building kinase inhibitors, antiviral leads, and some crop protection agents. Medicinal teams use it for “late-stage functionalization,” a process where the trifluoromethyl and bromine groups can both serve as points for shaping and fine-tuning a molecule’s final character. The CF3 group doesn’t just occupy space; it can nudge a molecule’s electron density and, in turn, affect where hydrogen bonds get made or broken during biological encounters.
The real story comes from the stories you hear in the lab—the kind of “I tried everything and then I switched to the bromo-trifluoromethyl pyridine, and the reaction just clicked.” Synthetic teams count on it because this building block often opens up new routes when others run into a wall. The amino group is reactive enough to form amides, ureas, or even pick up protecting groups as needed; meanwhile, the bromine handles coupling reactions efficiently. Cross-coupling, in particular, has helped cutting-edge scientists move drugs from idea to clinical candidate much faster than older approaches.
Plenty of pyridine derivatives flood the catalogs. What separates 2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine from run-of-the-mill building blocks comes down to two things: chemical intuition and actual application. The trifluoromethyl group sets a high bar. Fluorine, with its electronegativity, throws unique shade on reactivity. Chemists looking for metabolic resistance in their candidate molecules often turn to CF3 as a swap for a hydrogen or methyl. Unlike regular amino-pyridines, this compound resists metabolic oxidation better and can influence absorption characteristics, making it a regular pick for medicinal chemistry groups concerned with pharmacokinetics.
Bromine adds another strategic handle. Though iodinated compounds work for similar coupling reactions, they’re usually pricier and sometimes less stable on the bench. Chloro-pyridines, by contrast, tend to be less reactive in the very couplings that drive modern combinatorial chemistry. By walking the line between reactivity and accessibility, 2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine often outperforms simpler analogs. Each functional group adds utility but also a degree of flexibility for multi-step synthesis, helping labs explore fresh chemical space without unnecessary complications.
One experience stands out from my early career—an antiviral project delayed by sluggish coupling reactions using a chlorinated pyridine. Replacing it with the bromo-trifluoromethyl analog turned a nearly abandoned route into a workable one. Better yields, cleaner profiles, and less need for excess catalyst saved the day. Colleagues focused on kinases and cancer targets tell me similar tales. Results rarely depend on one reagent, but a building block that opens new chemistry can change an entire project’s fate.
For those worrying about handling and storage, this compound doesn’t throw many curveballs. Standard dry storage in dark bottles maintains its integrity, and it tolerates a fair bit of jostling during repeated weighing. Unlike certain moisture-sensitive boronic acids or aggressive alkylating agents, 2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine shows stability during normal use. Researchers and managers alike appreciate chemicals that help maintain focus on discovery rather than troubleshooting basic logistics.
Selecting among aromatic building blocks brings no shortage of options, but those with a balance of activating and leaving groups—like the bromine and trifluoromethyl here—lend themselves to more diverse chemistry. In one project on central nervous system drugs, our group faced the challenge of tweaking polarity and lipophilicity. The introduction of the CF3 unit nudged molecules toward better permeability, while the bromine left open the option for biaryl coupling. Rooting around for alternatives usually means trading off either coupling efficiency or downstream metabolic properties. I’ve seen teams avoid unnecessary synthetic acrobatics by starting with this versatile scaffold instead of plain aminopyridines.
Academic and commercial groups both benefit from time saved, but the real benefit often comes in discovery. Compound libraries built from modular pieces stand a better chance of turning up new hits, and combining adaptable functional groups increases the chance of landing on something novel. As a gateway to unexplored space, the 2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine shines. It acts as an amplifier for new ideas, especially when speed matters and resources run tight.
Translating bench chemistry into real-world impact takes more than isolated reactions. Many drugs on the market today started with a handful of carefully selected heterocyclic building blocks. In agricultural innovation, time counts—a new pesticide with the right toxicological and environmental profile means fewer lost crops, sustained food supply, and reduced risk from pest resistance. In pharma, the search for better, safer medicines always circles back to foundational choices in the lab. Compounds like this one don’t often make headlines themselves, but they’re woven into the story of each approved drug or improved field treatment.
The trifluoromethyl and bromo groups directly impact the journey from idea to shelf. As regulations grow stricter and emphasis on green chemistry tightens, chemists want compounds that reduce step counts, lower waste, and yield products likely to survive the long regulatory road. Every year, medicinal teams share papers highlighting the improvements that started with a simple building block swap—better dose profiles, fewer side effects, streamlined production. While one reagent rarely gets all the credit, those in the trenches know the ripple effects a well-chosen starting material can create.
Adding fluorine and bromine to molecules isn’t always straightforward. The environmental and safety backdrop to modern chemistry means researchers bear responsibility for how and why they use halogenated compounds. Careful waste handling, responsible sourcing, and a push for alternatives to perfluorinated legacy compounds all weigh on minds inside and out of the lab. Experience has shown that leaving out the trifluoromethyl group often means trading away stability or activity, so the practical solution becomes smarter handling rather than total avoidance.
Some teams explore catalytic trifluoromethylation as a late-stage tweak, aiming to minimize waste and cut the number of steps. Several studies have pointed to more selective, lower-temperature couplings using palladium or copper catalysis on brominated pyridines, which supports safer, lower-impact synthesis. Blending safer practices with clever reagent use is where I’ve seen research really take off—matching the right material to each challenge, using green chemistry principles for everything from solvent choice to purification. 2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine brings useful flexibility to these efforts, whether for scaling batch chemistry or for delicate, atom-efficient transformations.
Working through chemical supply challenges throws curveballs, too. Raw material shortages, regulatory shifts on fluorinated intermediates, and tightening restrictions on hazardous shipping have all affected project timelines in recent years. Sharing networks, reliable documentation, and transparent sourcing build trust between labs and suppliers. Teams that take the time to verify third-party testing and seek out partners with a track record of ethical and environmental standards gain more than peace of mind—they also support broader change in industrial practices.
As more therapeutic targets and resistant pests appear, the need for better starting materials stays strong. There is comfort knowing that science can lean on building blocks like 2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine when chasing the next big advance. In an industry where repeatability and accountability rank high, strong documentation and predictable reactivity make a real difference. Labs can plan wider, explore new targets with more confidence, and spend fewer hours troubleshooting unexpected side reactions from less stable or less pure alternatives.
Where scientific teams once relied on hit-or-miss building blocks, now they reference enormous libraries of well-characterized fragments, shaped by decades of lessons in medicinal, agrochemical, and materials chemistry. The overlap between these disciplines continues to grow, and compounds like this one serve as connectors. By linking different approaches—combining robust cross-coupling chemistry with the latest in bioisosteric design—2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine adds momentum to projects that often run up against scientific and economic barriers.
An example comes from a recent powerhouse collaboration between synthetic chemists and computational modelers. By using well-understood building blocks as standards, the modelers could refine their virtual screening to better predict which modifications would survive both the bench and biological assay. Bridging these worlds only works when starting materials have consistent, predictable behavior. That’s why this compound has popped up more and more in the patent landscape, on new applications for antiviral, antibacterial, and herbicidal innovations.
Frustration with “close enough” materials shaped the way I approached each research project. Too often, chasing low-cost or generic building blocks led to reproducibility headaches or, worse, wasted months repeating work. A lesson quickly learned: time and again, the peer-reviewed literature rewards groups that get the basics right—proven sources, full analytical characterization, and a willingness to question whether a slightly more complex building block (like 2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine) might unlock better results.
New researchers entering pharma or agrochemical labs often see the chemical catalog as an overwhelming list of unfamiliar names. Breaking it down, those with clustered functional groups—an amino for reactivity, a bromine for cross-coupling, and a trifluoromethyl for metabolic tuning—step out as the real workhorses. They stand up to the demands of the modern bench scientist, who faces pressure not just for speed but for downstream performance. This isn’t about simply ticking a box; rather, it’s about setting a project’s trajectory for success by starting smart.
With regulatory and environmental standards rising, some worry that specialty intermediates could become scarcer. Yet examples from the last decade show that careful selection and smart chemistry can go hand-in-hand with sustainability. As a bridge between disciplines, 2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine anchors both high-throughput screening programs and niche, target-focused syntheses. The more experience you rack up in tough synthetic campaigns, the more you value flexibility inside a molecule.
Experience on the bench echoes through published studies: the choice of starting fragments influences everything from yield to long-term stability and even market readiness. A single halogen or trifluoromethyl group can tip the balance. The deep bench of modern molecular medicine and crop protection relies on these seemingly small decisions. Building libraries with flavor, with built-in “handles” for derivatization and functional tuning, means new science moves from inspiration to demonstration faster—and more reliably.
I’ve watched as groups pivoted their whole approach mid-stream, reaching for this particular aminobromotrifluoromethyl pyridine to shake off stubborn bottlenecks. In some cases, it rescued new lead molecules from inactivity or metabolic instability, pushing programs back into the running after months on the shelf. In other cases, a well-placed CF3 or bromine unlocked unique selectivity profiles, creating molecules that fit in “chemical space” their designers might never have spotted using old-school screening.
At the end of the day, molecules like 2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine demonstrate the progress possible when chemists choose wisely. Instead of searching for fixes on the fly, new approaches start upstream—designing analogs, libraries, or candidate drugs with functional groups already set to maximize success. Research and development, whether at a university bench or inside a global company, need these reliable starting points.
Looking toward tomorrow’s challenges, the lesson from the last few decades rings true: great science comes from the intersection of chemical insight, practical experience, and a little luck, but smart building blocks stack the odds in your favor. Not every molecule deserves an editorial, but some—like 2-Amino-5-Bromo-3-(Trifluoromethyl)Pyridine—speak loudly in the language of innovation and repeatable progress.
